Menatrol
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Menatrol
- Generic name
- FOLATE, MULTIVITAMIN
- Manufacturer
- PureTek Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 0a100e7d-3a8d-2d8b-e063-6394a90a3203
- SPL ID
- 0a100e7d-3a8e-2d8b-e063-6394a90a3203
- Version
- 1
- Effective date
- 2023-12-18
- Source export date
- 2026-09-28
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:07:17
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Menatrol | openfda.brand_name | |
| generic name | FOLATE, MULTIVITAMIN | openfda.generic_name | |
| manufacturer name | PureTek Corporation | openfda.manufacturer_name | |
| ndc | package | 59088-156-54 | openfda.package_ndc |
| ndc | product | 59088-156 | openfda.product_ndc |
| ndc11 | package | 59088015654 | derived:openfda.package_ndc |
| spl id | 0a100e7d-3a8e-2d8b-e063-6394a90a3203 | id | |
| spl set id | 0a100e7d-3a8d-2d8b-e063-6394a90a3203 | set_id | |
| unii | H0G9379FGK | openfda.unii | |
| unii | G280W4MW6E | openfda.unii | |
| unii | 3A3U0GI71G | openfda.unii | |
| unii | A9R10K3F2F | openfda.unii | |
| unii | 68Y4CF58BV | openfda.unii | |
| unii | 1C6V77QF41 | openfda.unii |
Boxed warning cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings: Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breast-feeding. Consult your doctor. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient. Precautions Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia, since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions: Possible side effects may include gastrointestinal upset. If any side effects persist or worsen, discontinue use and consult a physician.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.